Jaguar Health (NASDAQ:JAGX) | Finanzwire

Basculer en Français

10446	Companies
219264	Keywords
148709	Articles
115976	Press releases

Home
Companies
Jaguar Health

BRIEF

published on 07/18/2024 at 16:35, 1 year 10 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Crofelemer on July 23rd

Crofelemer Webcast Jaguar Health OnTarget Trial Cancer Supportive Care
PRESS RELEASE

published on 07/18/2024 at 16:30, 1 year 10 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Jaguar Health announces webcast for cancer supportive care updates including OnTarget trial results. Make Cancer Less Shitty program expands with MCLS Ambassadors

Webcast Jaguar Health OnTarget Trial Cancer Supportive Care Make Cancer Less Shitty
BRIEF

published on 07/08/2024 at 16:35, 1 year 10 months ago

Jaguar Health Strengthens IP Protection with New European and Australian Patents

Crofelemer Jaguar Health Australian Patent European Patent SBS And CDDs
PRESS RELEASE

published on 07/08/2024 at 16:30, 1 year 10 months ago

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025

Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease

Accesswire

Published on 05/23/2026 at 19:45, 1 day 6 hours ago

Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 23 hours ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 23 hours ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 2 days ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 2 days ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec

View all ACCESSWIRE

EQS Group

Published on 05/25/2026 at 02:30, 10 minutes ago

SM Group raises renewable energy sourcing to 31% in 2025
Published on 05/24/2026 at 12:25, 14 hours 15 minutes ago

AutoFlight V5000 Matrix Concludes 'Heterogeneous Three-Aircraft Formation' Flight, Officially Kicks Off Airworthiness Certification
Published on 05/24/2026 at 05:55, 20 hours 45 minutes ago

The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 21 hours 5 minutes ago

CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 1 day 10 hours ago

HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking

Les Echos

Published on 05/22/2026 at 18:05, 2 days 8 hours ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 2 days 13 hours ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 2 days 18 hours ago

Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/21/2026 at 17:50, 3 days 8 hours ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 3 days 8 hours ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE